Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease

Periodontal disease (PD) is a prevalent inflammatory disease with the most severe consequence being the loss of the alveolar bone and teeth. We therefore aimed to evaluate the effects of telmisartan (TELM), an angiotensin II type 1 receptor (Agtr1) antagonist, on the PD-induced alveolar bone loss, i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Pharmacol
Main Authors: Brito, Victor Gustavo Balera, Patrocinio, Mariana Sousa, Linjardi, Maria Carolina, Barreto, Ayná Emanuelli Alves, Frasnelli, Sabrina CT, Lara, Vanessa, Santos, Carlos Ferreira, Oliveira, Sandra Helena Penha
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751694/
https://ncbi.nlm.nih.gov/pubmed/33364953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.579926
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares